Literature DB >> 24060173

Use of the LQ model with large fraction sizes results in underestimation of isoeffect doses.

Tommy Sheu1, Jessica Molkentine, Mark K Transtrum, Thomas A Buchholz, Hubert Rodney Withers, Howard D Thames, Kathy A Mason.   

Abstract

PURPOSE: To test the appropriateness of the linear-quadratic (LQ) model to describe survival of jejunal crypt clonogens after split doses with variable (small 1-6 Gy, large 8-13 Gy) first dose, as a model of its appropriateness for both small and large fraction sizes.
METHODS: C3Hf/KamLaw mice were exposed to whole body irradiation using 300 kVp X-rays at a dose rate of 1.84 Gy/min, and the number of viable jejunal crypts was determined using the microcolony assay. 14 Gy total dose was split into unequal first and second fractions separated by 4 h. Data were analyzed using the LQ model, the lethal potentially lethal (LPL) model, and a repair-saturation (RS) model.
RESULTS: Cell kill was greater in the group receiving the larger fraction first, creating an asymmetry in the plot of survival vs size of first dose, as opposed to the prediction of the LQ model of a symmetric response. There was a significant difference in the estimated βs (higher β after larger first doses), but no significant difference in the αs, when large doses were given first vs small doses first. This difference results in underestimation (based on present data by approximately 8%) of isoeffect doses using LQ model parameters based on small fraction sizes. While the LPL model also predicted a symmetric response inconsistent with the data, the RS model results were consistent with the observed asymmetry.
CONCLUSION: The LQ model underestimates doses for isoeffective crypt-cell survival with large fraction sizes (in the present setting, >9 Gy).
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Linear-quadratic model; Microcolony assay; Stereotactic body radiotherapy; Tolerance calculations

Mesh:

Year:  2013        PMID: 24060173     DOI: 10.1016/j.radonc.2013.08.027

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  13 in total

Review 1.  Radiobiological considerations in combining doses from external beam radiotherapy and brachytherapy for cervical cancer.

Authors:  Ana M Tornero-López; Damián Guirado
Journal:  Rep Pract Oncol Radiother       Date:  2018-07-02

Review 2.  Proton RBE dependence on dose in the setting of hypofractionation.

Authors:  Thomas Friedrich
Journal:  Br J Radiol       Date:  2019-08-28       Impact factor: 3.039

3.  The Limitations of Model-Based Experimental Design and Parameter Estimation in Sloppy Systems.

Authors:  Andrew White; Malachi Tolman; Howard D Thames; Hubert Rodney Withers; Kathy A Mason; Mark K Transtrum
Journal:  PLoS Comput Biol       Date:  2016-12-06       Impact factor: 4.475

4.  A model for relative biological effectiveness of therapeutic proton beams based on a global fit of cell survival data.

Authors:  Ramin Abolfath; Christopher R Peeler; Mark Newpower; Lawrence Bronk; David Grosshans; Radhe Mohan
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

5.  Re-irradiation for recurrent glioma- the NCI experience in tumor control, OAR toxicity and proposal of a novel prognostic scoring system.

Authors:  Andra Valentina Krauze; Cord Peters; Jason Cheng; Holly Ning; Megan Mackey; Lindsay Rowe; Theresa Cooley-Zgela; Dee Dee Smart; Kevin Camphausen
Journal:  Radiat Oncol       Date:  2017-11-29       Impact factor: 3.481

6.  A generalized target theory and its applications.

Authors:  Lei Zhao; Dong Mi; Bei Hu; Yeqing Sun
Journal:  Sci Rep       Date:  2015-09-28       Impact factor: 4.379

7.  Adaptive hypofractionated gamma knife radiosurgery for a large brainstem metastasis.

Authors:  Georges Sinclair; Jiri Bartek; Heather Martin; Pierre Barsoum; Ernest Dodoo
Journal:  Surg Neurol Int       Date:  2016-02-10

8.  Radiosensitivity and relative biological effectiveness based on a generalized target model.

Authors:  Lei Zhao; Di Wu; Dong Mi; Yeqing Sun
Journal:  J Radiat Res       Date:  2016-07-15       Impact factor: 2.724

Review 9.  The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.

Authors:  C M van Leeuwen; A L Oei; J Crezee; A Bel; N A P Franken; L J A Stalpers; H P Kok
Journal:  Radiat Oncol       Date:  2018-05-16       Impact factor: 3.481

10.  The impact of different stereotactic radiation therapy regimens for brain metastases on local control and toxicity.

Authors:  Rachel B Jimenez; Brian M Alexander; Anand Mahadevan; Andrzej Niemierko; Selvan Rajakesari; Nils D Arvold; Scott R Floyd; Kevin S Oh; Jay S Loeffler; Helen A Shih
Journal:  Adv Radiat Oncol       Date:  2017-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.